Fertility Preservation in Premature Ovarian Insufficiency (POI) Secondary to FSH Receptor Gene (FSHR) Mutation: Is There a New Hope?

  • Pradervand P
  • Antaki R
  • Phillips S
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A 19 years old patient with primary amenorrhea was referred to our center. Based on discrepancy between high follicle stimulating hormone (FSH) level and normal ovarian reserve parameters, follicle stimulating hormone receptor (FSHR) mutation was screened. The patient was homozygous in exon 6 of the FSHR gene for the new variant c.479T > C and predicted to result in an ami-noacid substitution p.Ile160Thr. One year later, her anti-müllerian hormone (AMH) level inexplicably decreased. Oocyte vitrification was thus offered for fertility preservation. After 17 days of recombinant follicle stimulating hor-mone (recFSH) (900 IU daily), no follicular growth was seen and estradiol le-vels remained low. In vitro maturation (IVM) was then suggested. Ten oo-cytes were successfully vitrified.

Cite

CITATION STYLE

APA

Pradervand, P.-A., Antaki, R., Phillips, S., Sylvestre, C., Haffaf, Z. E., Godbout, A., … Lehmann, P. (2017). Fertility Preservation in Premature Ovarian Insufficiency (POI) Secondary to FSH Receptor Gene (FSHR) Mutation: Is There a New Hope? Case Reports in Clinical Medicine, 06(10), 274–280. https://doi.org/10.4236/crcm.2017.610030

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free